Apollo Hospitals Enterprise Limited — Cyborg Score 8/10

Strong
Healthcare Services & Hospitals

Strategic Profile

Apollo delivered consolidated revenue of INR 6,304 crore in Q2 FY26 (up 13% YoY) with strong healthcare services margins of 24.6%. Management reaffirmed confidence in achieving 13% organic growth and 5% incremental growth from new hospitals over the next two years.

Cyborg Score Rationale

Net profit jumped 25.98% YoY to ₹477.20 Cr in Q2 FY26. Management targets 13% organic growth with 5% incremental growth from new hospital additions. Strong market position as Asia's largest integrated healthcare provider supports competitive moat and growth trajectory.

Top Insights

  • Insurance and cash patients together account for 83% of inpatient hospital revenue.
  • Company operates 10,200 bed capacity across 73 hospitals with 8,767 beds in 45 owned hospitals.
  • Apollo Hospitals was the first hospital company included in Nifty 50 benchmark index in March 2022.
  • Apollo Pharmacy operates the largest retail pharmacy chain in India with over 5,000 stores.

Named Competitors

  • Max Healthcare Institute — Multi-specialty hospital chain in India
  • Fortis Healthcare — Integrated healthcare delivery platform
  • Manipal Hospitals — Multi-specialty healthcare provider
  • Lilavati Hospital — Premium tertiary care hospital

Recent Developments

  • (Feb 2026) Q3 FY26 financial results announced with strong H1 FY26 performance across healthcare services, Apollo HealthCo, and AHLL
  • (Feb 2026) Board meetings completed for quarterly results and ongoing hospital expansion pipeline
  • (Jan 2026) Trading window closed for Q3 FY26 results announcement compliance

Open the full interactive Apollo Hospitals Enterprise Limited report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →